Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials.

NPJ breast cancer·2025
Same author

Reflections on the pigments of life.

Nature reviews. Chemistry·2025
Same author

Convection Enhanced Delivery in the Setting of High-Grade Gliomas.

Pharmaceutics·2021
Same author

Endpoint in ovarian cancer xenograft model predicted by nighttime motion metrics.

Lab animal·2020
Same author

Diastereoselective generation of triple-stranded helicates induced by gem-dimethyl groups on a linker.

Dalton transactions (Cambridge, England : 2003)·2012
Same author

Synthesis of triple-stranded complexes using bis(dipyrromethene) ligands.

Inorganic chemistry·2010
Same journal

Switching Site Selectivity in Alkoxyamine Hydration: From Lone-Pair Direction to Solvent Network Dominance.

Journal of the American Chemical Society·2026
Same journal

A Topotactic Leap: 2D Layers to 3D Large-Pore Zeolite.

Journal of the American Chemical Society·2026
Same journal

Enhanced Hydrogen Evolution over Single-Atom Catalysts via Electrostatic Polarization in Contact-electro-catalysis.

Journal of the American Chemical Society·2026
Same journal

Tumor Acidity-Activatable Ionizable Lipid Nanoparticles for Selective Oncolytic Therapy.

Journal of the American Chemical Society·2026
Same journal

Alternating Magnetic Field Promotes Ammonia Cracking by Disrupting the Sabatier Limitation of Ruthenium Catalytic Species.

Journal of the American Chemical Society·2026
Same journal

Bulk Ferromagnetic Icosahedral Quasicrystals without Rapid Quenching.

Journal of the American Chemical Society·2026
関連記事をすべて見る

関連する実験動画

Updated: Jul 6, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

可視光を用いたサイト固有の前薬の放出.

Michael Y Jiang1, David Dolphin

  • 1Department of Chemistry, University of British Columbia, Room W300 - 6174 University Boulevard, Vancouver, BC, V6T 1Z3, Canada.

Journal of the American Chemical Society
|March 14, 2008
PubMed
まとめ
この要約は機械生成です。

新しい光ダイナミックプロドラッグシステムは,可視光を使用して,光敏感剤複合体から薬物を放出します. この戦略は,NSAIDメチルエステルおよびverteporfinに関連する光敏感剤で実証された,標的の薬物投与および放出を可能にします.

さらに関連する動画

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
11:20

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation

Published on: August 30, 2017

関連する実験動画

Last Updated: Jul 6, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
11:20

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation

Published on: August 30, 2017

科学分野:

  • 薬用化学 薬用化学について
  • フォトケミストリー フォトケミストリー
  • 薬物の配送システムです.

背景:

  • 標的型薬剤投与システムを開発することは,治療効果を高め,副作用を最小限に抑えるために不可欠です.
  • フォトダイナミック戦略は,薬物の放出を空間時間的に制御し,活性化のために光を活用します.

研究 の 目的:

  • 薬物の制御された放出のために光敏感化とシングレット酸素化を活用した光ダイナミックなプロドラッグシステムを開発する.
  • 光敏感剤コンジュガートからカルボニルを含む薬物の組み込みと光誘発による放出を調査する.

主な方法:

  • 光敏感化-単一酸化-ダイオキセタン分裂戦略が採用されました.
  • カーボニル基を有する薬物は,光敏感剤 (verteporfin関連) に結合して複合体を形成した.
  • 薬物の放出を誘発するために,可視光照射が使用されました.

主要な成果:

  • 開発されたシステムは,光敏感剤コンジュガートから薬物模倣剤とNSAIDメチルエステルを成功裏に放出しました.
  • 薬剤の放出は,可視光照明によって数分以内に達成されました.
  • リリースされた薬物の高から量的な収量が観察されました.

結論:

  • 標的薬の放出のために,多用途の光ダイナミックプロドラッグシステムが成功裏に開発されました.
  • 可視光媒介のシングレット酸素生成は,正確な薬剤活性化のためのメカニズムを提供します.
  • このアプローチは,局所的な薬物投与を必要とする先進的な治療アプリケーションに期待を寄せている.